Summary:
A new genetic study finds that people with severe anorexia nervosa are almost four times more likely to carry rare, damaging variants in the PLIN4 gene. PLIN4 is chiefly expressed in adipose tissue and skeletal muscle rather than in the brain. This challenges the long-held view that anorexia is solely a brain-based psychiatric disorder and points to peripheral metabolic dysfunction in lipid storage as an important biological contributor.
Key Facts:
- Nearly 4× higher variant frequency: About 11% (17 of 154) of patients with severe anorexia carried rare variants predicted to damage PLIN4, compared with roughly 3% in a large healthy reference population.
- Peripheral fat-storage gene: PLIN4 is primarily active in body fat and skeletal muscle and helps regulate lipid droplet structure and cellular energy storage, not neural circuits.
- Familial co-segregation: Six patients had highly disruptive PLIN4 loss-of-function variants; in four families, the identical variant was also present in an affected first-degree relative.
Source: Michigan State University
Anorexia nervosa is among the psychiatric disorders with the highest mortality, driven by severe emaciation, cardiovascular complications, and increased suicide risk. Despite substantial heritability and decades of clinical investigation, treatment options remain limited, relying heavily on psychological therapy and nutritional rehabilitation, with no FDA-approved medications specifically for anorexia.
A study published in Frontiers in Psychiatry and supported by Michigan State University (MSU) offers genomic evidence that a peripheral metabolic defect — specifically in lipid-droplet biology — may increase susceptibility to anorexia nervosa. The investigators focused on patients with severe, treatment-resistant, or familial forms of the disorder and used whole-exome sequencing to search for rare, high-impact protein-coding variants.
Challenging the “Brain-Only” View
Anorexia has traditionally been viewed primarily as a psychiatric disorder rooted in distorted body image, compulsive behavior, and brain circuitry. This new work challenges that perspective by identifying a gene linked to fat storage rather than to nervous-system function.
“The prevailing bias is that anorexia is a purely psychiatric disorder,” said A.J. Robison, PhD, MSU Research Foundation Distinguished Professor of physiology and a study advisor. “Finding a gene mostly expressed in body fat and muscle flips that assumption and opens new avenues for understanding the biology of this disease.”
Lead investigator Michael Lutter, MD, PhD, and collaborators sequenced the exomes of 154 individuals with severe anorexia. They chose patients enriched for familial aggregation, multiple failed treatments, or unusual clinical courses to increase the chance of discovering rare, high-effect variants.
What PLIN4 Does
PLIN4 (Perilipin 4) is part of a conserved family of perilipin proteins that coat intracellular lipid droplets. It helps determine lipid-droplet architecture, regulate the storage and release of neutral lipids, and influence how adipose tissue and muscle manage energy reserves.
When PLIN4 function is impaired, adipocytes and muscle cells may struggle to store or mobilize fatty acids normally. The researchers propose that such dysfunction could alter peripheral hunger and satiety signaling, disrupt leptin and adipokine feedback to the hypothalamus, or make the biological experience of weight gain metabolically aversive — any of which could increase vulnerability to extreme dietary restriction.
Dr. Lutter likened the discovery of rare PLIN4 variants in some families to identifying high-impact oncogenic variants like BRCA1/2: while the disorder is polygenic and multifactorial, rare damaging variants in a critical metabolic regulator can substantially increase disease risk in particular families.
Study Findings and Significance
In their analysis, PLIN4 was the only gene among 32 candidates that reached Bonferroni-corrected significance for enrichment of rare, damaging variants. Specifically, 17 of 154 patients (11.0%) carried a rare damaging PLIN4 variant versus 3.2% in the gnomAD non-Finnish European reference group (odds ratio 3.86; one-sided Fisher p = 9.98×10−6; corrected p = 3.19×10−4). The signal remained significant after removing the index proband.
Six patients carried predicted loss-of-function PLIN4 variants; four of those six had at least one affected relative who carried the same variant, providing co-segregation evidence consistent with familial risk. Although the loss-of-function burden alone did not survive correction in isolation, the overall enrichment implicates lipid-droplet biology in anorexia pathophysiology.
Implications for Research and Treatment
The authors emphasize that these findings come from a selected clinical subpopulation and need replication in larger, diverse cohorts. Nonetheless, identifying a peripheral metabolic vulnerability creates new translational opportunities. Therapeutic strategies that correct or compensate for disrupted lipid storage and signaling in adipose tissue or muscle could complement psychological and behavioral treatments.
“Finding genes that contribute to the disease won’t cure anorexia immediately,” Robison said, “but it tells us what is causing the disease in many people, and that knowledge can guide the development of targeted therapies.”
Next steps include functional studies on primary adipocytes from patients carrying PLIN4 variants to observe lipid-droplet morphology and metabolic signaling, and to test whether interventions targeting peripheral lipid regulation reduce disease-related metabolic distress.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by staff editors.
About this Neurology Research:
- Media Contact: Bethany Mauger
- Source: Michigan State University
- Image Credit: Image credited to Neuroscience News
- Original Research (Open Access): Frontiers in Psychiatry (Oct 1, 2026). Title: “Increased frequency of rare damaging variants in PLIN4 in patients with anorexia nervosa.” Authors: Michael Lutter et al.
- DOI: 10.3389/fpsyt.2026.1937613
Abstract
Increased frequency of rare damaging variants in PLIN4 in patients with anorexia nervosa
Background: Anorexia nervosa (AN) is a severe psychiatric disorder marked by intense fear of weight gain, persistent restriction of energy intake, and body-image disturbance. Although AN has substantial heritability, the contribution of rare coding variants remains incompletely defined. Pedigree-based whole-exome sequencing can uncover rare, high-effect protein-coding variants and clarify disease mechanisms.
Methods: Whole-exome sequencing was performed on family pedigrees enriched for AN to identify candidate genes. Researchers assessed the frequency of rare (minor allele frequency <1%), predicted damaging variants [CADD >15, including predicted loss-of-function (LOF)] across 32 candidate genes in 154 unrelated probands of European ancestry. Carrier counts were compared with a gnomAD non-Finnish European reference using a coverage-adjusted denominator. Statistical significance used a one-sided Fisher exact test with Bonferroni correction for 32 genes.
Results: PLIN4 was the only gene significantly enriched after Bonferroni correction: 17 of 154 patients (11.0%) carried a rare damaging variant versus 3.2% in gnomAD non-Finnish Europeans (OR 3.86, 95% CI 2.35–6.35; one-sided Fisher p = 9.98×10−6; corrected p = 3.19×10−4). The finding persisted when the index proband was removed. Six patients carried predicted LOF variants; in four families, the same variant was present in an affected first- or second-degree relative, supporting co-segregation. The LOF-only signal did not survive correction independently.
Conclusions: Patients with anorexia nervosa show a statistically significant excess of rare, putatively damaging variants in PLIN4, implicating lipid-droplet biology as a candidate contributor to AN pathophysiology.
